NasdaqGS - Delayed Quote USD
Enanta Pharmaceuticals, Inc. (ENTA)
Tune into live earnings calls Now streaming directly on quote pages.
5.27
-0.05
(-0.94%)
At close: May 9 at 4:00:00 PM EDT
5.27
0.00
(0.00%)
After hours: May 9 at 4:05:06 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 112,500 | 7 |
| Sales | 15,756 | 6 |
| Net Shares Purchased (Sold) | 96,744 | 13 |
| Total Insider Shares Held | 1.4M | -- |
| % Net Shares Purchased (Sold) | 7.40% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| OR YAT SUN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| KIEFFER TARA LYNN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| LUU BRENDAN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| ROTTINGHAUS SCOTT T. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| MELLETT PAUL J JR Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| LULY JAY R Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| LULY JAY R Chief Executive Officer | Purchase at price 5.69 per share. | Direct | 256,050 | Feb 12, 2025 |
| MELLETT PAUL J JR Chief Financial Officer | Sale at price 8.06 per share. | Direct | 20,883 | Dec 6, 2024 |
| LULY JAY R Chief Executive Officer | Sale at price 8.06 per share. | Direct | 41,445 | Dec 6, 2024 |
| OR YAT SUN Officer | Sale at price 8.06 per share. | Direct | 20,883 | Dec 6, 2024 |
| KIEFFER TARA LYNN Officer | Sale at price 8.06 per share. | Direct | 18,401 | Dec 6, 2024 |
| LUU BRENDAN Officer | Sale at price 8.06 per share. | Direct | 18,401 | Dec 6, 2024 |
| ROTTINGHAUS SCOTT T. Officer | Sale at price 8.06 per share. | Direct | 6,980 | Dec 6, 2024 |
| ROTTINGHAUS SCOTT T. Officer | Sale at price 15.04 - 17.08 per share. | Direct | 190,747 | Jul 15, 2024 |
| ROTTINGHAUS SCOTT T. Officer | Conversion of Exercise of derivative security at price 8.99 per share. | Direct | 48,321 | Jul 15, 2024 |
| KIEFFER TARA LYNN Officer | Sale at price 12.33 per share. | Direct | 89,590 | Jun 17, 2024 |
| GARDINER NATHANIEL S Officer | Conversion of Exercise of derivative security at price 8.99 per share. | Direct | 46,631 | Feb 26, 2024 |
| GARDINER NATHANIEL S Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2024 |
| OR YAT SUN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2024 |
| KIEFFER TARA LYNN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2024 |
| LUU BRENDAN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2024 |
| ROTTINGHAUS SCOTT T. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2024 |
| MELLETT PAUL J JR Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2024 |
| LULY JAY R Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2024 |
| VANCE TERRY C. Director | Sale at price 9.12 per share. | Direct | 139,490 | Dec 13, 2023 |
| MELLETT PAUL J JR Chief Financial Officer | Sale at price 9.63 per share. | Direct | 23,228 | Dec 5, 2023 |
| LULY JAY R Chief Executive Officer | Sale at price 9.63 per share. | Direct | 69,625 | Dec 5, 2023 |
| GARDINER NATHANIEL S General Counsel | Sale at price 9.63 per share. | Direct | 23,228 | Dec 5, 2023 |
| OR YAT SUN Officer | Sale at price 9.63 per share. | Direct | 23,228 | Dec 5, 2023 |
| KIEFFER TARA LYNN Officer | Sale at price 9.63 per share. | Direct | 20,464 | Dec 5, 2023 |
| LUU BRENDAN Officer | Sale at price 9.63 per share. | Direct | 20,464 | Dec 5, 2023 |
| ROTTINGHAUS SCOTT T. Officer | Sale at price 9.63 per share. | Direct | 5,142 | Dec 5, 2023 |
Related Tickers
INVA Innoviva, Inc.
18.56
-0.11%
NRXS NeurAxis, Inc.
2.0000
-8.26%
MLYS Mineralys Therapeutics, Inc.
14.65
-6.15%
CGEM Cullinan Therapeutics, Inc.
7.54
-2.96%
RNXT RenovoRx, Inc.
1.0600
+1.92%
RLAY Relay Therapeutics, Inc.
3.0000
0.00%
VTVT vTv Therapeutics Inc.
20.80
-2.12%
LIXT Lixte Biotechnology Holdings, Inc.
1.2160
-1.94%
GBIO Generation Bio Co.
0.3600
+0.06%
OSRH OSR Holdings, Inc.
1.2500
-2.34%